全文获取类型
收费全文 | 2824篇 |
免费 | 185篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 98篇 |
妇产科学 | 52篇 |
基础医学 | 587篇 |
口腔科学 | 57篇 |
临床医学 | 155篇 |
内科学 | 742篇 |
皮肤病学 | 109篇 |
神经病学 | 212篇 |
特种医学 | 34篇 |
外科学 | 183篇 |
综合类 | 24篇 |
一般理论 | 1篇 |
预防医学 | 236篇 |
眼科学 | 54篇 |
药学 | 152篇 |
中国医学 | 14篇 |
肿瘤学 | 279篇 |
出版年
2023年 | 32篇 |
2022年 | 55篇 |
2021年 | 93篇 |
2020年 | 66篇 |
2019年 | 112篇 |
2018年 | 100篇 |
2017年 | 74篇 |
2016年 | 68篇 |
2015年 | 83篇 |
2014年 | 134篇 |
2013年 | 162篇 |
2012年 | 186篇 |
2011年 | 262篇 |
2010年 | 124篇 |
2009年 | 113篇 |
2008年 | 142篇 |
2007年 | 152篇 |
2006年 | 164篇 |
2005年 | 128篇 |
2004年 | 133篇 |
2003年 | 131篇 |
2002年 | 116篇 |
2001年 | 37篇 |
2000年 | 29篇 |
1999年 | 29篇 |
1998年 | 29篇 |
1997年 | 20篇 |
1996年 | 15篇 |
1995年 | 14篇 |
1994年 | 12篇 |
1993年 | 8篇 |
1992年 | 25篇 |
1991年 | 16篇 |
1990年 | 10篇 |
1989年 | 18篇 |
1988年 | 15篇 |
1987年 | 6篇 |
1986年 | 8篇 |
1985年 | 13篇 |
1984年 | 10篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1979年 | 10篇 |
1978年 | 4篇 |
1976年 | 5篇 |
1975年 | 4篇 |
1973年 | 6篇 |
1968年 | 4篇 |
排序方式: 共有3017条查询结果,搜索用时 42 毫秒
41.
Xavier Muñoz María José Álvarez-Puebla Ebymar Arismendi Lourdes Arochena María del Pilar Ausín Pilar Barranco Irina Bobolea Jose Antonio Cañas Blanca Cardaba Astrid Crespo Victora del Pozo Javier Domínguez-Ortega María del Mar Fernandez-Nieto Jordi Giner Francisco Javier González-Barcala Juan Alberto Luna Joaquim Mullol Iñigo Ojanguren María Jesús Cruz 《Archivos de bronconeumología》2018,54(7):378-385
The general aim of this study is to create a cohort of asthma patients with varying grades of severity in order to gain greater insight into the mechanisms underlying the genesis and course of this disease.The specific objectives focus on various studies, including imaging, lung function, inflammation, and bronchial hyperresponsiveness, to determine the relevant events that characterize the asthma population, the long-term parameters that can determine changes in the severity of patients, and the treatments that influence disease progression. The study will also seek to identify the causes of exacerbations and how this affects the course of the disease.Patients will be contacted via the outpatient clinics of the 8 participating institutions under the auspices of the Spanish Respiratory Diseases Networking System (CIBER). In the inclusion visit, a standardized clinical history will be obtained, a clinical examination, including blood pressure, body mass index, complete respiratory function tests, and FENO will be performed, and the Asthma Control Test (ACT), Morisky-Green test, Asthma Quality of Life Questionnaire (Mini AQLQ), the Sino-Nasal Outcome Test 22 (SNOT-22), and the Hospital Anxiety and Depression scale (HADS) will be administered. A specific electronic database has been designed for data collection. Exhaled breath condensate, urine and blood samples will also be collected. Non-specific bronchial hyperresponsiveness testing with methacholine will be performed and an induced sputum sample will be collected at the beginning of the study and every 24 months. A skin prick test for airborne allergens and a chest CT will be performed at the beginning of the study and repeated every 5 years. 相似文献
42.
Jorge L Cervantes Bennett Weinerman Chaitali Basole Juan C Salazar 《Cellular & molecular immunology》2012,9(6):434-438
The endosomal Toll-like receptors (TLRs) TLR3, TLR7, TLR8 and TLR9 are important in sensing foreign nucleic acids encountered by phagocytes. Because TLR8 was initially thought to be non-functional in mice, less is known about TLR8 than the genetically and functionally related TLR7. Originally associated with the recognition of single-stranded RNA of viral origin, there is now evidence that human TLR8 is also able to sense bacterial RNA released within phagosomal vacuoles, inducing the production of both nuclear factor (NF)-κB-dependent cytokines and type I interferons (IFNs), such as IFN-β. The functions of TLR8 extend beyond the recognition of foreign pathogens and include cross-talk with other endosomal TLRs, a process that may also have a role in the generation of autoimmunity. 相似文献
43.
44.
45.
Dovi Stéphanie Acouetey Denis Zmirou-Navier Patrice Avogbe Paul Tossa Thomas Rémen Annick Barbaud José-Antonio Cornejo-Garcia Miguel Blanca Abraham Bohadana Christophe Paris Jean-Louis Guéant Rosa-Maria Guéant-Rodriguez 《Annals of allergy, asthma & immunology》2013,110(6):423-428.e5
BackgroundThe influence of genetic predictors of inflammation and atopy on occupational asthma in apprentices is not known.ObjectivesTo assess the influence of genetic polymorphisms of IL4RA, IL13, TNFA, IL1A, and IL5 on the decline of lung function and bronchial hyperresponsiveness in a prospective follow-up study of baker/pastry maker and hairdresser apprentices.MethodsA total of 351 apprentices were included in the study. We performed skin testing, spirometry, fractional exhaled nitric oxide measurement, and methacholine hyperreactivity testing at the initial visit and during and at the end of the 18-month training period. Gene variants of IL4RA, IL13, TNFA, IL1A, and IL5 were determined in DNA from nasal lavage.ResultsIL13 R130Q/IL4RA S478P or IL13 R130Q//IL4RA Q551R were significant predictors of the decrease of forced expiratory volume and forced vital capacity (P ≤ .006). Genotype GG of TNFAG308A was associated with bronchial hyperresponsiveness in the whole population and in nonatopic individuals (90.63% vs 9.38%; odds ratio, 3.78; 95% confidence interval, 1.10-12.83). TNFA GA and IL5 CC and TNFA GA and IL1A CC were 2 epistatic predictors of exhaled nitrogen monoxide decrease during follow-up (P = .02 and P = .004, respectively). The association with TNFA GA and IL1A CC was the most significant in nonatopic bakers (P < .001).ConclusionWe evidenced a predicting influence of IL13/IL4RA and TNFA in the early exposure to allergens and irritants that precedes occupational asthma. The significance of the associations in the absence of atopy suggests an influence of the genetics predictors related to inflammatory pathways. 相似文献
46.
47.
Lucely Cetina Tania Crombet Roberto Jiménez-Lima Sergio Zapata Mayra Ramos Sandra Avila Jaime Coronel Eduardo Charco Rafael Bojalil Horacio Astudillo Blanca Bazán Alfonso Due?as-González 《Cancer biology & therapy》2015,16(5):684-689
Nimotuzumab is a humanized IgG1 monoclonal antibody against the EGFR extracellular domain that has been evaluated in solid tumors as a single agent or in combination with chemotherapy and radiation. Cervical cancer patients who are refractory or progressive to first-line chemotherapy have a dismal prognosis, and no second- or third-line chemotherapy is considered standard. This pilot trial aimed to evaluate the efficacy and safety of nimotuzumab in 17 patients with pre-treated advanced refractory or progressive cervical cancer. Nimotuzumab was administered weekly at 200 mg/m2 as single agent for 4 weeks (induction phase), then concurrent with 6 21-day cycles of gemcitabine (800 mg/m2) or cisplatin (50 mg/m2) for 18 weeks (concurrent phase) and then once every 2 weeks (maintenance phase). Nimotuzumab could be continued beyond disease progression. Seventeen patients were accrued and evaluated for safety and efficacy. The median number of nimotuzumab applications was 20 (5–96). The median number of chemotherapy cycles administered was 6 (1-6). No toxicity occurred during induction and maintenance phases (single agent nimotuzumab). In the concurrent phase, grade 3 toxicity events observed were leucopenia, anemia and diarrhea in 11.7%, 5.8% and 11.7% respectively. No complete or partial responses were observed. The stable disease (SD) rate was 35%. The median PFS and OS rates were163 days (95% CI, 104 to 222), and 299 days (95% IC, 177 to 421) respectively. Nimotuzumab is well tolerated and may have a role in the treatment of advanced cervical cancer. 相似文献
48.
49.
50.